Designed as a platform for medical professionals looking for information on GSCG and Regenestem conferences and meetings worldwide.
(PRWEB) July 20, 2015
Global Stem Cells Group has announced the launch of stemcellconference.org, the online go-to web page for information on any of the GSCG and Regenestem conferences or meetings worldwide. The site makes it easy for medical professionals to locate all the details available on any Global Stem Cells Group conference, with secure click-through registration capabilities straight from the site.
Upcoming events already accessible through stemcellconference.org include the Global Stem Cells Group Regenerative Medicine Symposiums to be held Sept. 3 in Santiago, Chile; Oct. 9 in Barcelona, Spain; Oct. 15 in Buenos Aires, Argentina; and March 19, 2016 in San Jose, Costa Rica.
The StemCellsConference.org page provides comprehensive details on all upcoming Global Stem Cells Group events, bios on GSCG Regenerative Medicine Symposium faculty members and presenters, product developers and other affiliates in the field of regenerative medicine, conference agendas, conference exhibitors, sponsors and partners, and more.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.